Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REP-PAF: Regenerative Cells for Anal Fistula
NCT06303752Phase 2Recruiting
- Sponsor
- University of Southern Denmark
- Start
- Oct 2024
- Primary completion
- Oct 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of culture-expanded adipose-derived regenerative cells in anal fistula, sponsored by University of Southern Denmark. Started Oct 2024; status: recruiting.
02
Drugs
culture-expanded adipose-derived regenerative cells
03
Conditions
anal fistula
Beyond the preview
Go deeper on NCT06303752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06303752.